Angiotensinogen, produced by the liver, is converted by renin into angiotensin I (Ang I), which is then cleaved into angiotensin II (Ang II)
Summary: Incretin mimetics (GLP-1 receptor agonists) generally do not cause hypoglycaemia when used alone due to their glucose-dependent mechanism, but the risk increases when combined with sulphonylureas or insulin
These mechanisms not only involve promoting muscle protein synthesis and inhibiting catabolism, but also cover the regulation of energy metabolism, the improvement of mitochondrial function, the alleviation of inflammatory responses, the regulation of autophagy processes, and the influence on muscle stem cell function
Niacin has also been reported to cause false-positive results in urine glucose tests that contain cupric sulfate solution (e.g., Benedicts reagent, Clinitest)
Oral vs injectable semaglutide
, NEJMoa2504214